BATON ROUGE, La., July 26, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of America’s leading home health and hospice care companies, announced today that it will report results for the second quarter ended June 30, 2016 after the market closes on August 2, 2016. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on August 3, 2016.
To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll). A replay of the conference call will be available through September 3, 2016. The replay dial-in number is (877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and reference conference ID #13641920.
A live webcast of the call will be accessible through our website on our Investor Relations section at the following web address: http://investors.amedisys.com .
Amedisys, Inc. (the “Company”) is headquartered in Baton Rouge, Louisiana with an executive office in Nashville, Tennessee and our common stock trades on the NASDAQ Global Select Market under the symbol “AMED”.
About Amedisys: Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 340,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com .
We use our company website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation, Nominating and Corporate Governance, Quality of Care and Compliance and Ethics Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").
Contact: Amedisys, Inc. David Castille Managing Director, Finance and Assistant Treasurer 225.299.3665 david.castille@amedisys.com
